In theory, if GLP-1s are affecting insulin levels and redirecting glucose into muscles, would they change the distribution pattern of FDG on a scan
David Strain,MD, FRCP, associate professor of cardiometabolic health at the University of Exeter Medical School in the United Kingdom, similarly not involved in the study, explained that: GLP-1 receptor antagonists and SGLT-2 inhibitors have been demonstrated to control the sugar, and also reduce the inflammation (a key driver of Alzheimers disease) and reduce vascular risk (a key driver of vascular dementia) more than would be expected by the sugar control alone. It is therefore no surprise that these data show a lower risk of dementia in people who receive them as part of her routine care, Strain continued
First, lets talk about specific foods that stimulate GLP-1 production in the body
Country-specific considerations Most Western countries, including Canada, the United Kingdom, Australia, and European Union member states, allow travelers to bring a 30 to 90 day personal supply of prescription medications with valid documentation